Confined or spread disease-Confined to the prostate gland - Page 8 of 13 Posts on Medivizor
Navigation Menu

Confined or spread disease-Confined to the prostate gland Posts on Medivizor

Lower PSA levels increase or decrease mortality risk depending on Gleason score

Posted by on May 21, 2016 in Prostate cancer | 0 comments

In a nutshell This study evaluated prostate-specific mortality risk based on PSA (prostate specific antigen) levels in men with high-grade disease. Authors reported increased mortality risk with lower PSA levels in men with high-grade disease. A decreased mortality risk was observed with lower PSA levels in men with low-grade disease. Some background...

Read More

Searching for men with early stage prostate cancer to test a short course of very focused radiation therapy

Posted by on May 9, 2016 in Prostate cancer | 0 comments

In a nutshell This phase 1/2 trial aims to evaluate the effectiveness of a short course of very focused radiation therapy in the treatment of early stage prostate cancer. The main outcome to be investigated is side effects and treatment response. The trial is recruiting in San Diego, California (USA). The details External beam radiation therapy...

Read More

Other medical conditions can affect cancer progression during active surveillance

Other medical conditions can affect cancer progression during active surveillance

Posted by on May 6, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the relationship between comorbidities (other medical conditions) and cancer progression during active surveillance. Researchers reported that progression is more likely among men with 2 or more comorbidities.  Some background Active surveillance of prostate cancer refers to actively monitoring tumor growth...

Read More

Are focal therapies an option for recurrent cancer?

Are focal therapies an option for recurrent cancer?

Posted by on Apr 23, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined the safety and effectiveness of focal therapies for recurrent localized prostate cancer. The authors concluded that there is early evidence to suggest that focal therapies are well-tolerated and effective for recurrent localized prostate cancer. Some background Radiation therapy is a common treatment for...

Read More

Searching for men with PSA levels rising after primary treatment to test an immunotherapy vaccine

Posted by on Apr 11, 2016 in Prostate cancer | 0 comments

In a nutshell This phase II trial aims to evaluate the effectiveness of a personalized peptide-based vaccine (Multi-Epitope TARP) on preventing progression of localized prostate cancer. The main outcome to be investigated is disease progression based on blood tests. The trial is recruiting in Maryland (USA). The details Immunotherapy has recently...

Read More

Low-risk prostate cancer: Predictors of disease progression during active surveillance

Posted by on Apr 2, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined predictors of disease progression in low-risk prostate cancer during active surveillance. Researchers concluded that certain blood markers, biopsy results, and ethnicity could help predict which patients were more likely to experience disease progression.  Some background Active surveillance of prostate...

Read More